Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 500.00
-5.00 (-0.99%)
Aug 1, 2025, 3:30 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 3.42 billion as of August 1, 2025. Its market cap has decreased by -54.09% in one year.
Market Cap
3.42B
Enterprise Value
1.53B
Revenue
72.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
500.00
Market Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 3.42B, a decrease of -32.78%. That is a compound annual growth rate of -8.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.42B | -42.50% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | 5.60B | 10.14% |
| Dec 28, 2020 | 5.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.11T |
| Daiichi Sankyo Company | 6,885.50B |
| HOYA Corporation | 6,574.11B |
| Takeda Pharmaceutical Company | 6,560.37B |
| Otsuka Holdings | 3,856.36B |
| Terumo | 3,777.35B |
| Astellas Pharma | 2,826.00B |
| Shionogi & | 2,166.10B |